Kenneth A. Freedberg

Expanded Screening for HIV in the United States — An Analysis of Cost-Effectiveness

A. David Paltiel, Milton C. Weinstein, April D. Kimmel et al. · New England Journal of Medicine · 2005 · 555 citations · Full text

Public Health, Infectious Disease Control, Pharmacoeconomics +14

HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost‐Effectiveness

A. David Paltiel, Kenneth A. Freedberg, Callie A. Scott et al. · Clinical Infectious Diseases · 2009 · 268 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection

Todd M. Allen, Marcus Altfeld, Xu G. Yu et al. · Journal of Virology · 2004 · 262 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness

Milton C. Weinstein, Sue J. Goldie, Elena Losina et al. · Annals of Internal Medicine · 2001 · 240 citations

Public Health, Pharmacoeconomics, Cost-effectiveness Analysis +16

Alcohol Consumption and Antiretroviral Adherence Among HIV‐Infected Persons With Alcohol Problems

Jeffrey H. Samet, Nicholas J. Horton, Seville Meli et al. · Alcoholism Clinical and Experimental Research · 2004 · 239 citations

Public Health, Infectious Disease Control, Hiv Control +15